Numb520 Spray
NDC Package 63742-034-01
Package Information
Numb520 (lidocaine, phenylephrine hydrochloride) sprays is clean the affected area.sensitivity and possible allergy tests advised prior to use. This formulation utilizes a spray delivery system. Marketed by Clinical Resolution Laboratory, Inc., this product is identified by NDC 63742-034 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 2590656 - lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Spray
- RxCUI: 2590656 - lidocaine 50 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Rectal Spray
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Local Anesthesia - [PE] (Physiologic Effect)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 63742 - Clinical Resolution Laboratory, Inc.
- 63742-034 - Numb520
- 63742-034-01 - 72 mL in 1 BOTTLE
- 63742-034 - Numb520
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63742-034-01 identifies a specific commercial package of 72 ml in 1 bottle of Numb520, a human over the counter drug labeled by Clinical Resolution Laboratory, Inc.. This spray is formulated for topical use and contains lidocaine; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Clinical Resolution Laboratory, Inc. on November 26, 2018. The current certification is valid through December 31, 2026.
How is this Clinical Resolution Laboratory, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63742003401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.